nach oben

memo - Magazine of European Medical Oncology

Inhalt (15 Artikel)

editorial

Antibody–drug conjugates (ADCs)—new targeted therapies

Georgios Papakonstantinou

editorial

Neurooncology: current findings and challenges for the future

Silvia Hofer

short review

ASCO 2013: news in early-stage and advanced breast cancer

Günther G. Steger, Rupert Bartsch

special report

Recent developments in the palliative treatment of breast cancer: ASCO 2013

Edgar Petru, Tina Idris, Vassilliki Kolovetsiou, Eva Schest

short review

ASCO 2013: new developments in lung cancer

Andreas Pircher, Michael Fiegl, Florian Kocher, Wolfgang Hilbe

short review

ASCO annual meeting 2013: head and neck cancer

Georg Pall

short review

ASCO 2013—treatment of metastatic melanoma: is it still a story of success?

Georg Weinlich

short review

Update on neurooncology Annual meeting of the American Society of Clinical Oncology (ASCO) 2013

Silvia Hofer, Christine Marosi

comment

ASCO 2013—new concepts and the path to individualized therapy

Heinz Zwierzina

short review

Transfusion-associated graft-versus-host disease: an update

Christian Dal-Pont, Harald Schennach

short review

The contribution of antibodies to targeted cancer therapy

Panagiotis Apostolou, Ioannis Papasotiriou

short review

Targeted delivery of anticancer agents using antibodies as vectors

Maria Toloudi, Ioannis Papasotiriou

review

T-DM1 in breast cancer therapeutics: the first drug of its generation

Michalis V Karamouzis

short review

Targeting AML with anti-CD33 antibodies: historical walkthrough, clinical impact, future directions

Spyridon Dimitrios Chondropoulos, Annaliza Delastic, Alexandros Spyridonidis

short review

Brentuximab vedotin, a highly active ADC as a new therapeutic option for CD30+ lymphomas

Sofia Stamatopoulou

Aktuelle Ausgaben

memo - Magazine of European Medical Oncology 1/2024
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology
memo - Magazine of European Medical Oncology 1/2024
memo - Magazine of European Medical Oncology 8/2023
A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer, September 9th-12th , hybrid congress
memo - Magazine of European Medical Oncology 9/2023
A CONGRESS DIGEST ON RADIOLABELED THERANOSTICS FOR SOLID TUMORS. Report from the 36th Annual Congress of the European Association of Nuclear Medicine (EANM), September 9th – 13th, 2023, Vienna
memo - Magazine of European Medical Oncology 4/2023
memo - Magazine of European Medical Oncology 10/2023
A GLOBAL CONGRESS DIGEST ON CHRONIC LYMPHOCYTIC LEUKEMIA. Report from International Workshop on Chronic Lymphocytic Leukemia (XX iwCLL 2023), 6th–9th October, 2023, Boston, USA
memo - Magazine of European Medical Oncology 11/2023
A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the ESMO Hybrid Congress , 20th – 24th October 2023, Madrid, Spain
memo - Magazine of European Medical Oncology 12/2023
A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES. Report from the American Society of Hematology (ASH) Annual Meeting, December 9–12, 2023
memo - Magazine of European Medical Oncology 3/2023
memo - Magazine of European Medical Oncology 7/2023
A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES. Report from the American Society of Clinical Oncology (ASCO) Annual Meeting (hybrid), 2nd-6th June 2023, European Hematology Association (EHA) 2023 Congress (hybrid), 8th-11th June 2023, and the 17th International Conference on Malignant Lymphoma (ICML) 2023 Congress (hybrid), 13th-17th June 2023

Scrollen für mehr

Benutzen Sie die Pfeiltasten für mehr

Scrollen oder Pfeiltasten für mehr

Springer Medizin Österreich

memo - Magazine of European Medical Oncology

Ausgabe 4/2013

Inhalt (15 Artikel)

Antibody–drug conjugates (ADCs)—new targeted therapies

Neurooncology: current findings and challenges for the future

ASCO 2013: news in early-stage and advanced breast cancer

Recent developments in the palliative treatment of breast cancer: ASCO 2013

ASCO 2013: new developments in lung cancer

ASCO annual meeting 2013: head and neck cancer

ASCO 2013—treatment of metastatic melanoma: is it still a story of success?

Update on neurooncology Annual meeting of the American Society of Clinical Oncology (ASCO) 2013

ASCO 2013—new concepts and the path to individualized therapy

Transfusion-associated graft-versus-host disease: an update

The contribution of antibodies to targeted cancer therapy

Targeted delivery of anticancer agents using antibodies as vectors

T-DM1 in breast cancer therapeutics: the first drug of its generation

Targeting AML with anti-CD33 antibodies: historical walkthrough, clinical impact, future directions

Brentuximab vedotin, a highly active ADC as a new therapeutic option for CD30+ lymphomas

Aktuelle Ausgaben

Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology

memo - Magazine of European Medical Oncology 1/2024

A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer, September 9th-12th , hybrid congress

A CONGRESS DIGEST ON RADIOLABELED THERANOSTICS FOR SOLID TUMORS. Report from the 36th Annual Congress of the European Association of Nuclear Medicine (EANM), September 9th – 13th, 2023, Vienna

memo - Magazine of European Medical Oncology 4/2023

A GLOBAL CONGRESS DIGEST ON CHRONIC LYMPHOCYTIC LEUKEMIA. Report from International Workshop on Chronic Lymphocytic Leukemia (XX iwCLL 2023), 6th–9th October, 2023, Boston, USA

A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the ESMO Hybrid Congress , 20th – 24th October 2023, Madrid, Spain

A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES. Report from the American Society of Hematology (ASH) Annual Meeting, December 9–12, 2023

memo - Magazine of European Medical Oncology 3/2023